Tiotropium bromide as add-on therapy to inhaled corticosteroids for treating asthma

Bibliography

• Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief 2012;94:1-8
   PubMedGoogle Scholar
• Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma 2009;46:73-80
   PubMed Web of Science ®Google Scholar
• European Lung Foundation. European Lung White Book. European Respiratory Society; Geneva: 2003
   Google Scholar
• Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002 – 2007. J Allergy Clin Immunol 2011;127:145-52
   PubMed Web of Science ®Google Scholar
• Bochner BS, Rothenberg ME, Boyce JA, Finkelman F. Advances in mechanisms of allergy and clinical immunology in 2012. J Allergy Clin Immunol 2013;131:661-7
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2014
   Google Scholar
• Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010(5):CD005535
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, et al. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170:836-44
   PubMed Web of Science ®Google Scholar
• Beasley R, Martinez FD, Hackshaw A, et al. Safety of long-acting beta-agonists: urgent need to clear the air remains. Eur Respir J 2009;33:3-5
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005;60:740-6
   PubMed Web of Science ®Google Scholar
• Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev 2004(3):CD003269
   Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65
   PubMed Web of Science ®Google Scholar
• Molimard M, D’Andrea P. Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile. Expert Rev Clin Pharmacol 2013;6(5):503-17
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci 1993;52:521-7
   PubMed Web of Science ®Google Scholar
• Wess. J Eglen RM, Gautam D, Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 2007;6:721-33
   Google Scholar
• Barnes PJ. The pharmacological properties of tiotropium. Chest 2000;117:63S-6S
   PubMed Web of Science ®Google Scholar
• Hohlfeld JM, Sharma A, van Noord JA, et al. Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease. J Clin Pharmacol 2014;54:405-14
   PubMed Web of Science ®Google Scholar
• Peters SP, Kunselman SJ, Icitovic N, et al. National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363:1715-26
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Casale TB, Bleecker ER, et al. Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials. Lancet Respir Med 2015; pii: S2213-2600(15)00031-4
   Google Scholar
• Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 2007;101:1218-28
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Disse B, Schröder-Babo W, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011;128:308-14
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012;367:1198-207
   PubMed Web of Science ®Google Scholar
• Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004;24:822-33
   PubMed Web of Science ®Google Scholar
• Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol 2013;6:197-219
   PubMed Web of Science ®Google Scholar
• Kang JY, Lee SY, Rhee CK, et al. Effect of aging on airway remodeling and muscarinic receptors in a murine acute asthma model. Clin Interv Aging 2013;8:1393-403
   PubMed Web of Science ®Google Scholar
• Magnussen H, Bugnas B, van Noord J, et al. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med 2008;102:50-6
   PubMed Web of Science ®Google Scholar
• Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 2006;7:73
   PubMed Web of Science ®Google Scholar
• Kistemaker LE, Oenema TA, Meurs H, Gosens R. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Life Sci 2012;91:1126-33
   PubMed Web of Science ®Google Scholar
• Elias JA, Zhu Z, Chupp G, et al. Airway remodeling in asthma. J Clin Invest 1999;104:1001-6
   PubMed Web of Science ®Google Scholar
• Bousquet J, Jeffery PK, Busse WB, et al. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Dolganov GM, Ferrando RE, et al. Hyperplasia of smooth muscle in mild/moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004;169:1001-6
   PubMed Web of Science ®Google Scholar
• Grainge CL, Lau LC, Ward JA, et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011;364:2006-15
   PubMed Web of Science ®Google Scholar
• Ohta S, Oda N, Yokoe T, et al. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy 2010;40:1266-75
   PubMed Web of Science ®Google Scholar
• Peters SP, Bleecker ER, Kunselman SJ, et al. Predictors of response to tiotropium versus salmeterol in asthmatic adults. J Allergy Clin Immunol 2013;132:1068-74
   PubMed Web of Science ®Google Scholar
• Kazani S, Israel E. Long-acting beta-agonists and inhaled corticosteroids: is the whole greater than the sum of its parts? J Allergy Clin Immunol 2010;125:357-8
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Kunselman SJ, Chinchilli VM, et al. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 2009;374:1754-64
   PubMed Web of Science ®Google Scholar
• Bateman ED, Kornmann O, Schmidt P, et al. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011;128:315-22
   PubMed Web of Science ®Google Scholar
• Singh S, Loke YK, Enright PL, Furberg CD. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2011;342:d3215
   PubMed Web of Science ®Google Scholar
• Pitcairn G, Reader S, Pavia D, Newman S. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler. Aerosol Med 2005;18:264-72
   PubMedGoogle Scholar
• Wise RA, Anzueto A, Cotton D, et al. TIOSPIR Investigators. Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med 2013;369:1491-501
   PubMed Web of Science ®Google Scholar
• Gross NJ. Anticholinergic agents in asthma and COPD. Eur J Pharmacol 2006;533:36-9
   PubMed Web of Science ®Google Scholar
• Mathur SK, Schwantes EA, Jarjour NN, Busse WW. Age-related changes in eosinophil function in human subjects. Chest 2008;133:412-19
   PubMed Web of Science ®Google Scholar
• Chalmers GW, MacLeod KJ, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest 2001;120:1917-22
   PubMed Web of Science ®Google Scholar
• Fairs A, Agbetile J, Hargadon B, et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010;182:1362-8
   PubMed Web of Science ®Google Scholar
• Birrell MA, Bonvini SJ, Dubuis E, et al. Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect? J Allergy Clin Immunol 2014;133:679-87
   PubMedGoogle Scholar